New Covenant Trust Company’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$250K Buy
690
+70
+11% +$24K 0.19% 87
2026
Q1
$218K Buy
+620
New +$221K 0.19% 88
2024
Q2
Sell
-534
Closed -$152K 95
2024
Q1
$152K Buy
+534
New +$156K 0.15% 95

Other funds holding AMGN

New Covenant Trust Company's AMGN Position: Q2 2026 in Review

New Covenant Trust Company increased its Amgen (AMGN) stake by 11% in Q2 2026, buying an estimated $24K and bringing the position to 690 shares worth $250K. The position accounts for 0.19% of the portfolio, ranked #87.

New Covenant Trust Company first reported a position in AMGN in Q1 2024 and has held it in 3 quarters since. 1,339 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • New Covenant Trust Company held 690 shares of Amgen worth $250K as of Q2 2026.
  • New Covenant Trust Company bought 70 Amgen shares in Q2 2026, an estimated $24K.
  • Amgen made up 0.19% of New Covenant Trust Company's portfolio in Q2 2026, its #87 holding.
  • New Covenant Trust Company first reported a position in Amgen in Q1 2024 and has held it in 3 quarters since.
  • 1,339 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on New Covenant Trust Company's 13F filing for Q2 2026, filed 14 Jul 2026.